Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis
Esther H. Lips(Oncode Institute), Hans Morreau(Leiden University Medical Center), Ronald van Eijk(Leiden University Medical Center), Tom M. Karsten(Reinier de Graaf Hospital), Noel F.C.C. de Miranda(Leiden University), Jan Oosting(Leiden University Medical Center), Paul H.C. Eilers(Leiden University), Eelco JR de Graaf(IJsselland Ziekenhuis), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Cornelis JH van de Velde(Leiden University), Tom van Wezel(Leiden University Medical Center)
Cited by 45
Related Papers
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer
|The Lancet|2009|890
Micrometastases and Survival in Stage II Colorectal Cancer
|New England Journal of Medicine|1998|601
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials.
|Journal of Clinical Oncology|1993|552
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
|Journal of Clinical Oncology|2010|540